Johnson & Johnson‘s startup arm JLABS is planning to open a 32,000-square foot facility which will be located at the new Children’s National Research and Innovation Campus in Washington, D.C, it was announced on April 9.
The facility, scheduled to be opened next year, will be launched in partnership with Children’s National Health System, the research hospital for kids. The JLABS site will offer services to pharmaceutical, medical device, consumer and health tech companies working on new drugs, medical devices, precision diagnostics and health technologies, including those working on pediatrics.
Paul Stoffels, Chief Scientific Officer and Vice Chairman of the Executive Committee of Johnson & Johnson, said that for over 130 years the Johnson & Johnson Family of Companies has been combining heart, science, and ingenuity to profoundly change the trajectory of health for humanity.
It’s official! #JNJ Innovation is teaming up with @childrenshealth to bring @JLABS to Washington, D.C. The 32k sq ft life science incubator will be housed at the new Children’s National Research & Innovation Campus. @JNJnews #JLABSDC #ObviouslyDC https://t.co/wKaRFQ5b4c pic.twitter.com/DExZPVLeQk
— Johnson & Johnson Innovation (@JNJInnovation) April 9, 2019
“JLABS is an integral part of our external innovation strategy designed to help catalyze the development of new healthcare solutions globally. We are delighted to launch JLABS @ Washington, D.C. in this uniquely vibrant and diverse life sciences ecosystem of world-class medical research centers, universities and government entities that can help us address some of the world’s most critical emerging health threats,” said Stoffels.
President and CEO of Children’s National Health System Kurt Newman said that the vision for this campus required a global innovation partner with a strong commitment to pediatric health and a clear understanding of the next big areas of opportunity for improving human health. “We believe the JLABS model is exactly what is needed to help us drive discoveries that are then rapidly translated into new treatments and technologies,” said Newman.
D.C. Mayor Muriel Bowser said that the city has the talent, ideas, and passion to support a robust healthcare industry, biotech sector, and tech scene. “We are proud to welcome Johnson & Johnson Innovation as they join Children’s National on the historic Walter Reed campus. This combination of a world-class children’s hospital and biotech incubator will drive discoveries that save lives, create jobs, and further strengthen D.C.’s status as the capital of inclusive innovation,” said Bowser.
The Washington, D.C. location adds to an increasing number of JLABS branches including San Diego, San Francisco and South San Francisco in California, Boston, and Lowell in Massachusetts, Houston, Toronto, New York City, Beerse, Belgium, and Shanghai, China, which is opening this summer.